These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37437516)

  • 41. Selective effects of oral antiangiogenic tyrosine kinase inhibitors on an animal model of hereditary hemorrhagic telangiectasia.
    Kim YH; Kim MJ; Choe SW; Sprecher D; Lee YJ; P Oh S
    J Thromb Haemost; 2017 Jun; 15(6):1095-1102. PubMed ID: 28339142
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of anterior palatine blocks on bleeding in hereditary hemorrhagic telangiectasia nasal surgery.
    Guthrie CC; Karnezis TT; Orosco RK; Bishop ML; Davidson TM
    Laryngoscope; 2013 Nov; 123(11):2598-600. PubMed ID: 23670536
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bevacizumab for treating Hereditary Hemorrhagic Telangiectasia patients with severe hepatic involvement or refractory anemia.
    Vázquez C; Gonzalez ML; Ferraris A; Bandi JC; Serra MM
    PLoS One; 2020; 15(2):e0228486. PubMed ID: 32032395
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does any lower gastrointestinal bleeding in patients suffering from hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu) necessitate a full colonic visualization?
    Elinav E; Salameh-Giryes S; Ackerman Z; Goldschmidt N; Nissan A; Chajek-Shaul T
    Int J Colorectal Dis; 2004 Nov; 19(6):595-8. PubMed ID: 15168045
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output.
    Dupuis-Girod S; Ginon I; Saurin JC; Marion D; Guillot E; Decullier E; Roux A; Carette MF; Gilbert-Dussardier B; Hatron PY; Lacombe P; Lorcerie B; Rivière S; Corre R; Giraud S; Bailly S; Paintaud G; Ternant D; Valette PJ; Plauchu H; Faure F
    JAMA; 2012 Mar; 307(9):948-55. PubMed ID: 22396517
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bleeding risk of cerebrovascular malformations in hereditary hemorrhagic telangiectasia.
    Willemse RB; Mager JJ; Westermann CJ; Overtoom TT; Mauser H; Wolbers JG
    J Neurosurg; 2000 May; 92(5):779-84. PubMed ID: 10794291
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: a series of 126 patients.
    Cottin V; Chinet T; Lavolé A; Corre R; Marchand E; Reynaud-Gaubert M; Plauchu H; Cordier JF;
    Medicine (Baltimore); 2007 Jan; 86(1):1-17. PubMed ID: 17220751
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Anticoagulation status and adherence in patients with atrial fibrillation hospitalized for ACS and the impact on 1-year prognosis: a multicenter cohort study].
    Zhu LY; Li Q; Yu LY; Liu Y; Chen YN; Wang Z; Zhang SY; Li J; Liu Y; Zhao YL; Xi Y; Pi L; Sun YH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Jul; 51(7):731-741. PubMed ID: 37460427
    [No Abstract]   [Full Text] [Related]  

  • 49. SMAD4 mutation and the combined juvenile polyposis and hereditary hemorrhage telangiectasia syndrome: a single center experience.
    McDonald NM; Ramos GP; Sweetser S
    Int J Colorectal Dis; 2020 Oct; 35(10):1963-1965. PubMed ID: 32556653
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence and characteristics of brain arteriovenous malformations in hereditary hemorrhagic telangiectasia: a systematic review and meta-analysis.
    Brinjikji W; Iyer VN; Wood CP; Lanzino G
    J Neurosurg; 2017 Aug; 127(2):302-310. PubMed ID: 27767404
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hereditary hemorrhagic telangiectasia (HHT): a practical guide to management.
    Hammill AM; Wusik K; Kasthuri RS
    Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):469-477. PubMed ID: 34889398
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hereditary hemorrhagic telangiectasia: systemic therapies, guidelines, and an evolving standard of care.
    Al-Samkari H
    Blood; 2021 Feb; 137(7):888-895. PubMed ID: 33171488
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Links Between Strokes and Hereditary Hemorrhagic Telangiectasia: A Population-Based Study.
    Chowdhury FN; Chandrarathne GS; Masilamani KD; LaBranche JTN; Malo S; Svenson LW; Jeerakathil T; Vethanayagam DP
    Can J Neurol Sci; 2019 Jan; 46(1):44-50. PubMed ID: 30520389
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical Practice Guideline: Nosebleed (Epistaxis).
    Tunkel DE; Anne S; Payne SC; Ishman SL; Rosenfeld RM; Abramson PJ; Alikhaani JD; Benoit MM; Bercovitz RS; Brown MD; Chernobilsky B; Feldstein DA; Hackell JM; Holbrook EH; Holdsworth SM; Lin KW; Lind MM; Poetker DM; Riley CA; Schneider JS; Seidman MD; Vadlamudi V; Valdez TA; Nnacheta LC; Monjur TM
    Otolaryngol Head Neck Surg; 2020 Jan; 162(1_suppl):S1-S38. PubMed ID: 31910111
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Successful therapy with bevacizumab in a case of hereditary hemorrhagic telangiectasia.
    Kochanowski J; Sobieszczańska M; Tubek S; Żurek M; Pawełczak J
    Hum Vaccin Immunother; 2015; 11(3):680-1. PubMed ID: 25839219
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and safety of novel oral anticoagulants in patients with cervical artery dissections.
    Caprio FZ; Bernstein RA; Alberts MJ; Curran Y; Bergman D; Korutz AW; Syed F; Ansari SA; Prabhakaran S
    Cerebrovasc Dis; 2014; 38(4):247-53. PubMed ID: 25401389
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epistaxis in children and adolescents with hereditary hemorrhagic telangiectasia.
    Gonzalez CD; Mcdonald J; Stevenson DA; Whitehead KJ; Petersen MG; Presson AP; Ding Q; Wilson KF
    Laryngoscope; 2018 Jul; 128(7):1714-1719. PubMed ID: 29171658
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of patients with hereditary hemorrhagic telangiectasia with video capsule endoscopy: a single-center prospective study.
    Chamberlain SM; Patel J; Carter Balart J; Gossage JR; Sridhar S
    Endoscopy; 2007 Jun; 39(6):516-20. PubMed ID: 17554646
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effects of anticoagulant therapy re-initiation after gastrointestinal bleeding: A systematic review and meta-analysis.
    Bingzheng X; Jingnan R; Ligang B; Jianping C
    J Clin Pharm Ther; 2021 Dec; 46(6):1509-1518. PubMed ID: 34101229
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pulmonary Arteriovenous Malformations Are Associated with Silent Brain Infarcts in Hereditary Hemorrhagic Telangiectasia Patients.
    Brinjikji W; Nasr DM; Wood CP; Iyer VN
    Cerebrovasc Dis; 2017; 44(3-4):179-185. PubMed ID: 28746925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.